Skip to content
Review

Unravelling the phytochemical complexity of neuroprotective plants: a metabolomics approach to Alzheimer’s disease

Aug 2026 · Molecular Biology Reports · Vol 53 · 0 citations · 104 references
Medicine

TL;DR

This review will highlight recent metabolomics discoveries on unravelling the complex phytochemical composition of selected medicinal plants in producing neuroprotective bioactive compounds and therapeutic potential to combat neurodegenerative related disease especially Alzheimer’s disease (AD).

View source

Similar papers

Open access Sep 2026

Metabonomics and it’s Potential Application in Clinic Diagnosis and Therapy

Metabolomics is a new-generation omics technology emerging after genomics, transcriptomics, and proteomics, It focuses on all small-molecule metabolites with molecular weights below 1 kDa within biological systems, providing a direct reflection of the terminal phenotypic changes in the physiological and pathological st...

Chun-Lei Xie, Cong-Cong Tang, Qi Tang et al. · 0 citations
Review Open access Sep 2026

Integrating multi-omics in natural product research: Bridging bioinsecticide discovery and drug development

Natural products remain significant sources of bioactive compounds for agriculture and medicine, though conventional discovery approaches are constrained by complex biosynthetic pathways, low metabolite yields, rediscovery of known compounds and labour-intensive screening. The combination of multi-omics technologies su...

Akash Kishor Rokade, Ha Nguyen · 0 citations
Review Open access Sep 2026

Metabolomics-guided natural product discovery for degenerative diseases: Chemometric strategies, bioactive marker validation, and methodological challenges.

Degenerative diseases impose a growing global health burden, whereas currently available therapies remain limited by adverse effects, drug resistance, and variable clinical efficacy. This critical narrative review used a structured, database-informed search of PubMed, Scopus, and ScienceDirect to identify original stud...

Indah Solihah, A. N. Garmana, N. Happyana et al. · 0 citations
Open access Sep 2026

Neuroprotective Potential of the Edible Seaweed Pterocladiella capillacea: Bioactivity Coupled LC-MS/MS, Metabolomics Annotation, Validation, and Network Pharmacology

Background: Alzheimer’s disease (AD) is a complex neurodegenerative disorder with a global impact, highlighting an urgent need for effective dietary therapeutic agents for the development of brain-healthy functional foods and medicines. This study focuses on the edible red alga Pterocladiella capillacea from Zhanjiang,...

Mei-Cai Yue, Long-Jian Zhou, Wan-Rong He et al. · 0 citations
Open access Aug 2026

Integrative network pharmacology and molecular modeling approaches reveal the therapeutic potential of Syzygium samarangense phytocompounds against diabetes retinopathy

These multi-target interactions suggest that S. samarangense phytochemicals can modulate key DR-associated pathways, and exhibits promising multi-target activity against Diabetes retinopathy.

Arun Kandhan, B. Mathew, Sundarrajan Thirugnanasambandam · 0 citations
Review Open access Sep 2026

Medicinal mushrooms and type 2 diabetes: mechanistic insights, translational evidence, and clinical caveats

Type 2 diabetes mellitus (T2DM) is a highly prevalent and rapidly expanding global metabolic disorder. Medicinal mushrooms have recently been proposed as promising functional foods, owing to their broad range of bioactive compounds, including β-glucans and other polysaccharides, triterpenoids, phenolic metabolites, ste...

Radoslav Z. Pavlović, J. Novaković, G. Ramenskaya et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.